title: [The improvement of safe sedation and dental treatment in patients with metabolic syndrome].
abstract: The paper concerns the anesthetic aspects of safe conscious sedation and dental treatment of patients with metabolic syndrome. BIS monitoring in combination with routine pulse oximetry and blood pressure measurement is getting dental sedation safer. Independently of the bolus or continuous intravenous midazolam infusion the investigators approved high efficacy of bispectral index in benzodiazepine dose titration. Successful dental treatment under conscious sedation and no evident associated with analgesia complications show the importance of BIS-monitoring in the improvement of safe sedation and dental treatment in patients with metabolic syndrome.
authors.forename: A S
authors.initials: AS
authors.lastname: Dobrodeev
authors.forename: S A
authors.initials: SA
authors.lastname: Rabinovich
authors.forename: G A
authors.initials: GA
authors.lastname: Remez
mesh_terms: D000328:Adult; D000368:Aged; D000766:Anesthesia, Dental / Q000009:adverse effects*; D000771:Anesthesia, Intravenous / Q000009:adverse effects*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D016292:Procedural Sedation / Q000009:adverse effects*; D003729:Dental Care; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects*; D007275:Injections, Intravenous; D008297:Male; D024821:Metabolic Syndrome / Q000503:physiopathology*; D008874:Midazolam / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D016343:Monitoring, Intraoperative / Q000379:methods*
chemical_list: D018686:Anesthetics, Intravenous; D006993:Hypnotics and Sedatives; D008874:Midazolam